» Articles » PMID: 23602156

Prevalence and Treatment of Anti-NMDA Receptor Encephalitis

Overview
Journal Lancet Neurol
Specialty Neurology
Date 2013 Apr 23
PMID 23602156
Citations 13
Authors
Affiliations
Soon will be listed here.
Citing Articles

Risk Factors and Prognosis in Anti-NMDA Receptor Encephalitis Patients with Disturbance of Consciousness.

Gong Z, Lao D, Huang F, Lv S, Mao F, Huang W Patient Relat Outcome Meas. 2023; 14:181-192.

PMID: 37337520 PMC: 10277025. DOI: 10.2147/PROM.S411260.


Treatment Options in Refractory Autoimmune Encephalitis.

Dinoto A, Ferrari S, Mariotto S CNS Drugs. 2022; 36(9):919-931.

PMID: 35917105 PMC: 9477937. DOI: 10.1007/s40263-022-00943-z.


Anti-N-methyl-D-aspartate-receptor antibody encephalitis combined with syphilis: A case report.

Li X, Shi Z, Guan Y, Ji Y World J Clin Cases. 2020; 8(12):2603-2609.

PMID: 32607338 PMC: 7322422. DOI: 10.12998/wjcc.v8.i12.2603.


Unusual case of anti-N-methyl-D-aspartic acid-receptor (NMDA-R) encephalitis and autoimmune polyglandular syndrome (APS).

Frunza-Stefan S, Whitlatch H, Rao G, Malek R BMJ Case Rep. 2018; 2018.

PMID: 29724875 PMC: 5935153. DOI: 10.1136/bcr-2018-224821.


Case report of anti-N-methyl-D-aspartate receptor encephalitis in a middle-aged woman with a long history of major depressive disorder.

Rong X, Xiong Z, Cao B, Chen J, Li M, Li Z BMC Psychiatry. 2017; 17(1):320.

PMID: 28859632 PMC: 5580214. DOI: 10.1186/s12888-017-1477-x.